Your browser doesn't support javascript.
loading
Endonuclease FEN1 Coregulates ERα Activity and Provides a Novel Drug Interface in Tamoxifen-Resistant Breast Cancer.
Flach, Koen D; Periyasamy, Manikandan; Jadhav, Ajit; Dorjsuren, Dorjbal; Siefert, Joseph C; Hickey, Theresa E; Opdam, Mark; Patel, Hetal; Canisius, Sander; Wilson, David M; Donaldson Collier, Maria; Prekovic, Stefan; Nieuwland, Marja; Kluin, Roelof J C; Zakharov, Alexey V; Wesseling, Jelle; Wessels, Lodewyk F A; Linn, Sabine C; Tilley, Wayne D; Simeonov, Anton; Ali, Simak; Zwart, Wilbert.
Afiliação
  • Flach KD; Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Periyasamy M; Oncode Institute, the Netherlands.
  • Jadhav A; Division of Gene Regulation, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Dorjsuren D; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
  • Siefert JC; National Center for Advancing Translational Sciences, NIH, Bethesda, Maryland.
  • Hickey TE; National Center for Advancing Translational Sciences, NIH, Bethesda, Maryland.
  • Opdam M; Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Patel H; Oncode Institute, the Netherlands.
  • Canisius S; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, Faculty of Health Sciences, University of Adelaide, Adelaide, South Australia.
  • Wilson DM; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Donaldson Collier M; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
  • Prekovic S; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Nieuwland M; Laboratory of Molecular Gerontology, Intramural Research Program, National Institute on Aging, NIH, Baltimore, Maryland.
  • Kluin RJC; Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Zakharov AV; Oncode Institute, the Netherlands.
  • Wesseling J; Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Wessels LFA; Oncode Institute, the Netherlands.
  • Linn SC; Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Tilley WD; Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Simeonov A; National Center for Advancing Translational Sciences, NIH, Bethesda, Maryland.
  • Ali S; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Zwart W; Oncode Institute, the Netherlands.
Cancer Res ; 80(10): 1914-1926, 2020 05 15.
Article em En | MEDLINE | ID: mdl-32193286
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Resistencia a Medicamentos Antineoplásicos / Endonucleases Flap / Receptor alfa de Estrogênio Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Resistencia a Medicamentos Antineoplásicos / Endonucleases Flap / Receptor alfa de Estrogênio Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2020 Tipo de documento: Article